Man Group’s Aehr Test Systems AEHR Stock Holding History

Man Group’s Portfolio AEHR Stock Details AEHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-16,580	Closed	-$168K	–	2031
2022 Q1	$168K	Buy	+16,580	New	+$212K	﹤0.01%	1974

Other funds holding AEHR

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AAS

Ameritas Advisory Services Lincoln, Nebraska $2.58B AUM 18.84% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Friess Associates Greenville, Delaware $59.9M AUM 3.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Man Group's AEHR Position: Q2 2022 in Review

Man Group sold out of Aehr Test Systems (AEHR) in Q2 2022, closing a stake of 16,580 shares — an estimated $168K sold.

Man Group first reported a position in AEHR in Q1 2022 and held it in 1 quarter. The position peaked at $168K in Q1 2022. 70 funds tracked by Wall St. Rank hold AEHR as of Q2 2022.

Man Group reported no remaining Aehr Test Systems position as of Q2 2022 after selling out during the quarter.
Man Group sold 16,580 Aehr Test Systems shares in Q2 2022, an estimated $168K.
Man Group first reported a position in Aehr Test Systems in Q1 2022 and held it in 1 quarter.
Man Group's Aehr Test Systems position peaked at $168K in Q1 2022.
70 funds tracked by Wall St. Rank held Aehr Test Systems as of Q2 2022.

Based on Man Group's 13F filing for Q2 2022, filed 15 Aug 2022.